Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, Inc., to its Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pervasis Therapeutics, Inc., a biotechnology company pioneering regenerative biologically active therapies and devices to treat serious illnesses, today announced the appointment of Frank Litvack, M.D., Professor, David Geffen School of Medicine, University of California, Los Angeles, and former chairman and chief executive officer of Conor Medsystems, to its Board of Directors.